Enoyl-CoA hydratase
Enoyl-CoA hydratase (ECH) is an enzyme that plays a crucial role in the metabolism of fatty acids by catalyzing the hydration of enoyl-CoA to 3-hydroxyacyl-CoA. This reaction is a key step in the beta oxidation pathway, which is the process by which fatty acids are broken down to generate acetyl-CoA, a vital molecule for energy production in cells. Enoyl-CoA hydratase exists in two forms: a short-chain enzyme active on acyl-CoA derivatives with a chain length of four to six carbon atoms, and a long-chain enzyme that acts on substrates with chain lengths of eight to sixteen carbon atoms.
Function[edit | edit source]
Enoyl-CoA hydratase catalyzes the second step in the beta oxidation cycle. Specifically, it converts the trans double bond between the second and third carbon atoms of an unsaturated acyl-CoA to a hydroxyl group, resulting in a 3-hydroxyacyl-CoA. This reaction is essential for the degradation of fatty acids to produce energy, particularly during periods when carbohydrates are scarce.
Structure[edit | edit source]
The enzyme is found in both the mitochondria and peroxisomes, indicating its importance in cellular energy metabolism across different organelles. The mitochondrial and peroxisomal forms of the enzyme are encoded by separate genes, which reflects the enzyme's evolutionary adaptation to specific cellular environments and functions.
Mechanism[edit | edit source]
Enoyl-CoA hydratase operates through a covalent catalysis mechanism. The enzyme has an active site that binds to the enoyl-CoA substrate. A glutamate residue in the active site then acts as a base, abstracting a proton from water, which is then added to the second carbon of the enoyl-CoA. Simultaneously, a histidine residue donates a proton to the third carbon, completing the hydration of the double bond to form 3-hydroxyacyl-CoA.
Clinical Significance[edit | edit source]
Mutations in the genes encoding enoyl-CoA hydratase can lead to metabolic disorders, including Leigh syndrome and multiple acyl-CoA dehydrogenase deficiency (MADD). These conditions are characterized by impaired energy production and accumulation of fatty acids and their derivatives, which can be toxic to cells.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD